9th Trends in Medical Mycology - Nice-Acropolis Convention Center Second announcement Nice, France - 10th Trends in Medical ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
11 – 14 October 2019
Nice-Acropolis
Convention Center
Nice, France
Second announcement
9th Trends in Medical Mycology
WWW.TIMM2019.ORG
Important dates
1 May Deadline early-bird registration fee
1 June Abstract deadline
July Abstracts letters of acceptance will be mailed
1 August Deadline late breaking abstracts*
16 September Deadline regular registration fee
* for information on late breaking abstract requirements see www.timm2019.org
See congress website for the latest information:
www.TIMM2019.org
Trends in Medical Mycology is the bi-annual joined meeting of the Infectious Disease
Group of the European Organisation for Research and Treatment of Cancer (EORTC) and
European Confederation of Medical Mycology (ECMM)
ECMM Society Office & Organisation
Congress Care
P.O. Box 440
5201 AK ‘s-Hertogenbosch
The Netherlands
Tel +31-73-690-1415
timm@congresscare.com
www.congresscare.com
2
Introduction
Dear Friends and Colleagues,
It is a great honour and pleasure for us to invite you cordially to participate in the 9th Congress
on Trends in Medical Mycology (TIMM-9), which will be held in October 11-14, 2019 at
Nice-Acropolis Convention Center, Nice, France. TIMM-9 is the 9th in the series of TIMM
mycological international meetings organized jointly by the European Confederation of
Medical Mycology (ECMM) and the Infectious Diseases Group of the European
Organisation for Research and Treatment of Cancer (EORTC-IDG).
TIMM has become an important and essential meeting in the field of fungal infections, a
forum in which researchers and clinicians from all over the world present the most important
advances and research findings in clinical mycology. TIMM-9 will cover all aspects of mycology
with special focus on evidence-based and personalized approach to medical mycology,
as well as diagnostic-therapeutic integrative efforts in the quest to improve the present
knowledge of epidemiology, diagnosis, clinical course and pathophysiological mechanisms
of fungal diseases. It would be the place to present recent innovations in medical mycology.
The meeting is designed for medical microbiologists, medical mycologists, heamatologists,
oncologists, transplant physicians, intensivists, immunologists, and all those with interest
in medical mycology. We expect TIMM-9 to be at least as successful as previous TIMM
Congresses, which brought together around 1,000 international delegates from all over
the world. Therefore, we would like to invite you to TIMM-9 in Nice to enjoy with us
excellent science in a stimulating environment.
We look forward to greeting you in Nice!
Jean-Pierre Gangneux
Olivier Lortholary
Oliver A. Cornely
Livio Pagano
TIMM-9 Executive Committee
3
4
Committees
Executive Committee
Jean-Pierre Gangneux, ECMM, France
Olivier Lortholary, EORTC, France
Livio Pagano, EORTC, Italy
Oliver A. Cornely, ECMM, Germany
International Scientific Committee
Hamdi Akan, EORTC, Turkey
Valentina Arsić Arsenijević, ECMM, Serbia
Sharon Chen, ECMM, Australia
Raoul Herbrecht, EORTC, France
Martin Hoenigl, ECMM, Austria
Nikolai Klimko, ECMM, Rusland
Katrien Lagrou, ECMM, Belgium
Johan Maertens, EORTC, Belgium
Jacques F. Meis, ECMM, the Netherlands
Tony Pagliuca, EORTC, UK
Zděnek Racil, EORTC, Czech Republic
Ester Segal, ECMM, Israel
Don Sheppard, ECMM, Canada
Paul Verweij, EORTC, the Netherlands
Thomas Walsh, ECMM, USA
Local Scientific Committee
Jean-Pierre Gangneux, Rennes
Olivier Lortholary, Paris
Alexandre Alanio, Paris
Jean-Philippe Bouchara, Angers
Marie-Elizabeth Bougnoux, Paris
Stephane Bretagne, Paris
Christophe D’Enfert, Paris
Jean-Paul Latgé, Paris
Laurence Millon, Besançon
5
Programme at a glance
FRIDAY 11 OCTOBER 2019
09:00 - 12:00 ECMM council meeting
12:00 - 12:30 Coffee break
12:30 - 12:45 Welcome address
12:45 - 13:45 Plenary session 1 - Tropical
13:45 - 15:15 Parallel Symposia 1-4
S1 S2 S3 S4
Water quality Pneumocystis ucormycosis
M MSG
(mis-)management jirovecii, an symposium (Trial
– an opportunity airborne Design in Clinical
transmissible
for fungal conta- Mycology: Innova-
and human
mination derived tive Approaches)
ascomycete
showing strong
pulmonary tropism
15:15 - 15:30 Coffee break
15:30 - 16:30 Sponsored Diagnostic Symposium
16:45 - 18:15 Sponsored Integrated Symposium 1
18:30 - 19:00 E. Drouhet lecture (ECMM)
19:00 - 20:00 Welcome reception
6
SATURDAY 12 OCTOBER 2019
08:00 - 08:45 Meet the expert sessions
M1 M2 M3 M4 M5
Hematology Peadiatrics Candida ICU Diagnostics/ Tropical
Laboratory
08:50 - 10:00 Plenary session 2 - Highlights on fungal biology
10:00 - 10:30 Coffee break
10:30 - 11:30 Plenary session 3 - One World One Guideline ECMM MSG-ERC (EFISG)
ISHAM Guidelines initiative
11:30 - 12:30 Poster session 1
12:30 - 14:15 Lunch
12:30 - 14:00 Sponsored Integrated Symposium 2
14:15 - 15:45 Parallel Symposia 5-9
S5 S6 S7 S8 S9
Lung trans- Prophylaxis Paediatric Immunologic Chronic
plantation during Mycology Markers for pulmonary
hematology (EPMyN) Diagnosis and aspergillosis
malginances Treatment
Stratification in
Invasive Mold
Infection
15:45 - 16:15 Coffee break
16:15 - 17:35 Parallel Symposia 10-14
S10 S11 S12 S13 S14
Sensing the The anti-fun- Environment Fungal Teaching
host gal pipeline & fungal respiratory Medical
outbreaks infections in Mycology:
cystic fibrosis what, how, to
(ECMM/ whom and
ISHAM when
working
Group Fri-CF)
18:00 - 19:30 Sponsored Integrated Symposium 3
19:30 - 20:30 Sponsored reception
7
Programme at a glance
SUNDAY 13 OCTOBER 2019
08:00 - 08:45 Meet the expert sessions
M6 M7 M8 M9 M10
Hematology - Molecular Surgery / Neonates Meet Mr. and
hematopic diagnostics transplantation Mrs. Fungus
stem cell HST
08:50 - 09:50 Plenary session 4 - Top 10 papers in Mycology
09:50 - 10:00 ECMM Academy and Excellence Centers: A story of success
10:00 - 10:30 Coffee break
10:30 - 11:30 lenary session 5 - ICU - candida infections /
P
Breaking news from Hematology and ICU
11:30 - 12:30 Poster session 2
12:30 - 14:15 Lunch
12:30 - 14:00 Sponsored Integrated Symposium 4
14:15 - 15:45 Parallel Symposia 15-19
S15 S16 S17 S18 S19
Aspergillis in Derma HIV associated Antifungal Pneumocystis
ICU crypto stewardship
meningitis in the era of
resistance
15:45 - 16:15 Coffee break
16:15 - 17:45 Parallel Symposia 20-24
S20 S21 S22 S23 S24
Candida auris Immuno- NGS and The funny life Fungal
therapy for mycobiota of C. albicans neglected
opportunistic in the oral tropical
fungal tract diseases
infections
18:00 - 19:00 Ben De Pauw Lectures (EORTC)
19:30 Congress dinner
8
MONDAY 14 OCTOBER 2019
08:00 - 08:45 Meet the expert sessions
M11 M12 M13 M14 M15
HIV Environment Diagnostics / Resistance Registries
imaging
08:50 - 10:00 Plenary session 6 - Management of IFD in paediatrics (EPMyN)
10:00 - 10:30 Coffee break
10:30 - 11:30 Plenary session 7 - Superficial & Derma
11:30 - 12:30 Plenary session 8 - New (antineoplastic) drugs, new risks
12:30 Closing TIMM-9
9
TIMM-9, Scientific Programme
Friday 11 October 2019
09:00 - 12:00 ECMM council meeting
12:00 - 12:30 Coffee break
12:30 - 12:45 Welcome address
12:45 - 13:45 Plenary session 1 - Tropical
PS1.1 Histoplasmosis
PS1.2 Emergomycosis
13:45 - 15:15 Parallel Symposia 1-4
Water quality (mis-)management –
an opportunity for fungal contamination
S01.1 Fungal contaminants in drinking water regulation?
A tale of ecology, exposure, purification and clinical
relevance
S01.2 Hospital environment: water supply and containment of
aerosolised fungal particles. How far must we go in times
of antimicrobial resistance?
S01.3 Potential transmission pathways of clinically relevant fungi
in indoor swimming pool facilities
Selected abstracts
Pneumocystis jirovecii, an airborne transmissible and
human derived ascomycete showing strong pulmonary
tropism
S02.1
Pneumocystis jirovecii: an obligate parasite of human lungs
with unique camouflage and sex strategies
S02.2 High-throughput methodologies in molecular
epidemiology of Pneumocystis jirovecii
10S02.3 Airborne acquisition and transmission of Pneumocystis
jirovecii: an update
S02.4 Pneumocystis in non-traditional risk groups
Mucormycosis
S03.1 Hospital related mucormycosis
S03.2 Presentation from Ramstein airbase
S03.3 The new treatment of mucormycosis
S03.4 Clinical features associated to fungal speci
S03.5 Molecular diagnosis
S03.6 Management of Mucormycosis in Low and Middle Income
Countries
MSG symposium (Trial Design in Clinical Mycology:
Innovative Approaches)
S04.1 Candidiasis
S04.2 Endemic Mycoses
S04.3 Cryptococcosis
S04.4 Aspergillosis and other molds
15:15 - 15:30 Coffee break
15:30 - 16:30 Sponsored Diagnostic Symposium
16:45 - 18:15 Sponsored Integrated Symposium 1
18:30 - 19:00 E. Drouhet lecture (ECMM)
19:00 - 20:00 Welcome reception
11Saturday 12 october 2019
08:00 - 08:45 Meet the expert sessions 1-5
M01 Hematology
M02 Peadiatrics
M03 Candida ICU
M04 Diagnostics/Laboratory
M05 Tropical
08:50 - 10:00 Plenary session 2 - Highlights on fungal biology
PS 2.1 Candida
PS 2.2 Aspergillus
Selected abstracts
10:00 - 10:30 Coffee break
10:30 - 11:30 Plenary session 3 - One World One Guideline ECMM
MSG-ERC (EFISG) ISHAM Guidelines initiative
PS3.1 Mucormycosis
PS3.2 Endemic
PS3.3 Rare moulds
PS3.4 Rare yeasts
11:30 - 12:30 Poster session 1
12:30 - 14:15 Lunch break
12:30 - 14:00 Sponsored Integrated Symposium 2
1214:15 - 15:45 Parallel Symposia 5-9
Lung transplantation
S05.1 Pre-transplant assesment
S05.2 Prophylaxis
S05.2 Current guidelines
Selected abstracts
Prophylaxis during hematology malginances
S06.1 AML - in the era of FLT3 inhibitors
S06.2 ALL - there is a role for prophylaxis
S06.3 Personalised medicine / approach by genetic risk factors
S06.4 Baseline CT upon diagnosis of Acute leukemia
Paediatric Mycology (EPMyN)
S07.1 Fluconazole and micafungin dosing in neonates
S07.2 Antifungal susceptibility of paediatric candidemia
S07.3 Primary immunodeficiencies characterized by fungal
infections
Selected abstracts
Immunologic Markers for Diagnosis and Treatment
Stratification in Invasive Mold Infection
S08.1 Anti-Mold Immune Response: the impact of the host, the
pathogen and translational implications
S08.2 Immunologic Markers for Diagnosis of invasive
Aspergillosis and other invasive Mold infections
S08.3 Immunologic Markers for Treatment Stratification in
Invasive Mold Infection
13S08.4 Multicenter Study: Immunologic Markers for Treatment
Monitoring and Diagnosis in Invasive Mold Infection
Chronic pulmonary aspergillosis
S09.1 The global burden of chronic pulmonary aspergillosis
S09.2 Diagnosis of CPA. Where do we stand?
S09.3 Current treatment options for CPA
S09.4 Future directions
15:45 - 16:15 Coffee break
16:15 - 17:35 Parallel Symposia 10-14
Sensing the host
S10.1 Phosphate acquisition and virulence in human fungal
pathogens
S10.2 Hybrid histidine kinases: major sensing proteins in
pathogenic fungi
S10.3 CO2 sensing in fungi: at the heart of metabolic signaling
Selected abstracts
S11 The anti-fungal pipeline
Environment & fungal outbreaks
S12.1 Frogs
S12.2 Cryptococcus - gattii
S12.3 Natural disasters
S12.4 Genomic sequencing
14Fungal respiratory infections in cystic fibrosis (the
ECMM/ISHAM working Group Fri-CF)
S13.1 Rasamsonia species and other emerging fungi in CF
S13.2 Immunodiagnosis of Scedosporium/Lomentospora
infection - lessons from immunoproteomic studies
S13.3 Bacterial / Fungal interactions in the CF mucus
Selected abstracts
Teaching Medical Mycology: what, how, to whom
and when
S14.1 Mycology teaching in Medical School - How much, what
to choose, at what level
S14.2 Mycology teaching in Medical School - Is student
demography important to what should be taught
S14.3 Specific courses outside European Continent - The Indian
Example
S14.4 Teaching Clinical Laboratory Mycology - How and who is
the audience
S14.5 The African example
18:00 - 19:30 Sponsored Integrated Symposium 3
19:30 - 20:30 Sponsored reception
15Sunday 13 october 2019
08:00 - 08:45 Meet the expert sessions 6-10
M6 Hematology - hematopic stem cell HST
M7 Molecular diagnostics
M8 Surgery / transplantation
M9 Neonates
M10 Meet Mr. and Mrs. Fungus
08:50 - 09:50 Plenary session 4 - Top 10 papers in Mycology
PS4.1 Clinical mycology
PS4.2 Microbiology
09:50 - 10:00 ECMM Academy and Excellence Centers: A story of success
10:00 - 10:30 Coffee break
10:30 - 11:30 Plenary session 5 - ICU - candida infections /
Breaking news from Hematology and ICU
PS5.1 Peritonitis
PS5.2 Are the new management strategies useful?
PS5.3 CNS infections
PS5.4 CMV and aspergillosis in HSCT patients
11:30 - 12:30 Poster session 2
12:30 - 14:15 Lunch
12:30 - 14:00 Sponsored Integrated Symposium 4
1614:15 - 15:45 Parallel Symposia 15-19
Aspergillis in ICU
S15.1 Influenza
S15.2 Invasive aspergillosis in patients with underlying liver
cirrhosis
Selected abstracts
Derma
S16.1 Malassezia infections. Too insignificant to mention?
S16.2 Is resistance a problem for dermatophytosis?
S16.3 Phaeohyphomycosis
S16.4 Blastomycosis
Selected abstracts
HIV associated crypto meningitis
S17.1 Screening in low-resource area
S17.2 Current therapeutic strategies
S17.3 Towards having antifungal drugs in low-resource area
S17.4 Early versus delayed antiretroviral treatment in HIV-positive
people with cryptococcal meningitis
S18 Antifungal stewardship in the era of resistance
17Pneumocystis
S19.1 Diagnosis
S19.2 Pneumocystosis and HIV
S19.3 Pneuomcystosis in non-HIV patients
S19.4 Pneumocystosis in neonates
15:45 - 16:15 Coffee break
16:15 - 17:45 Parallel Symposia 20-24
Candida auris
S20.1 In resource limited countries
S20.2 In the US
S20.3 Outbreak control
Selected abstracts
Immunotherapy for opportunistic fungal infections
S21.1 CAR-T cells, NK cells
S21.2 WBC transfusions
S21.3 Cytokines
Selected abstracts
NGS and mycobiota
S22.1 Respiratory Mycobiome in Chronic Airway Inflammatory
Diseases and Emerging Relationships with the Host
Immune Response
S22.2 Respiratory Mycobiome – A Clinical Perspective
S22.3 Characterization of indoor dust microbiota in homes of
asthma and non asthma patients
18S22.4 Understanding the role of the gut mycobiome in health
and diseas
Selected abstracts
The funny life of C. albicans in the oral tract
S23.1 Within-Host Genomic Diversity of Candida albicans in
Healthy Carriers
S23.2 Rapid phenotypic and genotypic diversification after
exposure to the oral host niche in Candida albicans
S23.3 Modulation of the Fungal-Host Interaction by the Intra-
Species Diversity of C. albicans
S23.4 Intestial Th17 drives airway inflammation in ABPA
Fungal neglected tropical disease
S24.1 Mycetome
S24.2 Chromoblastomycosis
S24.3 Sporotrichosis
Selected abstracts
18:00 - 19:00 Ben De Pauw Lectures (EORTC)
19:30 Congress dinner
19Monday 14 october 2019
08:00 - 08:45 Meet the expert sessions 11-15
M11 HIV
M12 Environment
M13 Diagnostics / imaging
M14 Resistance
M15 Registries
08:50 - 10:00 Plenary session 6 - Management of IFD in paediatrics
(EPMyN)
PS6.1 Biomarker based diagnostic work-up of IFD in
immunocompromised paediatric patients
PS6.2 Pre-emptive versus empiric antifungal therapy in in children
with cancer
Selected abstracts
10:00 - 10:30 Coffee break
10:30 - 11:30 Plenary session 7 - Superficial & Derma
PS7.1 When the skin is the porter of invasive infections
PS7.2 When the skin talks for systemic infections
11:30 - 12:30 Plenary session 8 - New (antineoplastic) drugs, new risks
PS8.1 In hematology
PS8.2 In oncology
12:30 Closing TIMM-9 & presentation TIMM-10
20Registration fees
Early Bird Regular Late
(1 May ‘19) (until 16 Sept ‘19) (from 16 Sept ‘19
and on-site)
ECMM/EORTC- members EUR 495 EUR 795 EUR 975
Non-members EUR 775 EUR 1095 EUR 1295
Physicians/scientists in training* EUR 395 EUR 595 EUR 795
Day-registration EUR 400 EUR 400 EUR 400
Emerging Economy Rate** EUR 195 EUR 300 EUR 395
Conditions
* Physicians/scientists in training have to provide a written certification by the head
of department.
** E merging Economy Rate is applied to individuals (no group registrations) from
low-income and lower-middle-income economies according to the World Bank
listing available at the website of the World Bank.
What is included in the registration fee?
The registration fee for delegates includes: Admission to the meeting,
welcome reception, certificate of attendance, 2 lunches and all coffee breaks.
Congress dinner Sunday
Dinner tickets are available at the price of EUR 100. Please make your reservation
when you register online.
Registration & payment
Registration is possible via the congress website. Payment can be done online by:
creditard (Mastercard / Visa) or SEPA direct debit.
Group registrations
For group registrations; please contact the congress secretariat via:
timm@congresscare.com, before starting your group registration.
Group registration is available for groups of 5 participants or more.
Cancellation
Cancellations and refund requests must be submitted in writing to the congress
secretariat. Cancellations made before 1 July 2019 will be refunded less 30% to
cover administration costs. After this date no refunds will be given. All refunds will
be made after the congress.
21General information
Location
TIMM-9 will be held in the Nice-Acropolis Convention Center, Nice, France. The Nice
Côte d’Azur Airport is France’s second-largest international airport. It is located 15
minutes from the Acropolis (7 km from the city centre). Several hotels are situated on
walking distance of the congress center.
Nice has an excellent public transport system with stops in front of the congress
center. For more info please check: www.timm2019.org.
Timing
The congress will start on Friday 11 October 2019 with registration, symposia, keynote
lectures, sponsored symposia, opening ceremony and welcome reception. The
congress will end on Monday 14 October 2019 at noon.
Abstract deadline
The deadline for abstract submission is 1st of June 2019. For more information please
see the section abstracts on the congress website.
Congress language
The official language of the congress will be English. No simultaneous translation will
be available.
Exhibition & sponsored symposia
A targeted group of biotechnical and pharmaceutical companies will be invited to
organise a sponsored integrated symposium and/or exhibit their products and services.
Insurance
In registering for the 9th Trends in Medical Mycology delegates agree that neither
the organisation nor the congress agency Congress Care is responsible for individual
medical, travel or personal insurance. Delegates are requested to arrange their own
travel and health insurance. The organizers cannot assume liability for changes in the
program due to external circumstances.
22Major sponsors (per April 2019)
Sponsors and exhibitors
23WWW.TIMM2019.ORG ECMM Society Office & Congress Organisation Congress Care P.O. Box 440 5201 AK ‘s-Hertogenbosch The Netherlands Tel +31-73-690-1415 timm@congresscare.com www.congresscare.com
You can also read
